NCT07226154
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Pancreatic Ductal Adenocarcinoma
Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
184 public trials
73 recruiting studies
Pancreatic Ductal Adenocarcinoma trial results
NCT06673017
- Conditions
- Borderline Resectable Pancreatic Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Northwell Health Zuckerberg Cancer Center Lake Success, New York, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07562152
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
- Locations
-
- City of Hope Phoenix, Arizona, United States
- City of Hope Duarte, California, United States
- Medical Oncology Hematology Consultants Newark, Delaware, United States
- Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
Recruiting
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
NCT07629960
- Conditions
- Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
- Locations
-
- Next Oncology Virginia Cancer Specialist Fairfax, Virginia, United States
- Florida Cancer Specialists & Research Institute - Sarasota Sarasota, Florida, United States
Recruiting
AB122 Platform Study
NCT04999761
- Conditions
- Advanced or Metastatic Solid Tumor, Alveolar Soft Part Sarcoma, Biliary Tract Cancer, +41 more
- Locations
-
- A site selected by Taiho Pharmaceutical Co., Ltd. Aichi, Japan
- A site selected by Taiho Pharmaceutical Co., Ltd. Chiba, Japan
- A site selected by Taiho Pharmaceutical Co., Ltd. Ehime, Japan
- A site selected by Taiho Pharmaceutical Co., Ltd. Hokkaido, Japan
NCT05132504
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Baylor College of Medicine Houston, Texas, United States
- Baylor St. Luke's Medical Center (BSLMC). Houston, Texas, United States
- Houston Methodist Hospital Houston, Texas, United States
NCT06128551
- Conditions
- Adenocarcinoma, Adnexal Diseases, Appendiceal Neoplasms, +59 more
- Locations
-
- City of Hope Duarte, California, United States
- UC IRVINE Health Orange, California, United States
- UC Davis Comprehensive Cancer Center Sacramento, California, United States
- Stanford Cancer Institute Stanford, California, United States
NCT04657068
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adnexal Diseases, +55 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Mayo Clinic (Arizona) Scottsdale, Arizona, United States
- University of Arkansas - Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT06218914
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +32 more
- Locations
-
- Research Site Duarte, California, United States
- Research Site Los Angeles, California, United States
- Research Site Newport Beach, California, United States
- Research Site Jacksonville, Florida, United States
NCT06320717
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Locations
-
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
- Good Samaritan University Hospital West Islip, New York, United States